Luisa Hector
Stock Analyst at Berenberg Bank
(4.11)
# 1,659
Out of 5,119 analysts
301
Total ratings
65.5%
Success rate
7%
Average return
Main Sectors:
Stocks Rated by Luisa Hector
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 350.00 | CHF 390.30 | -10.33% | 57 | Nov 4, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €105.00 | €83.74 | +25.39% | 55 | Nov 4, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 15,000p | 13,930p | +7.68% | 76 | Oct 16, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $275 | $291.31 | -5.60% | 20 | Sep 10, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $125 → $127 | $146.73 | -13.45% | 35 | Aug 5, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 92.00 → CHF 110.00 | CHF 133.08 | -17.34% | 4 | Mar 6, 2026 | |
| LON: BTRW Barratt Redrow plc | Reiterated: Hold | 414p | 333p | +24.44% | 1 | Feb 11, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,660p | 1,890p | -12.17% | 7 | Jan 6, 2026 | |
| SNY Sanofi | Reiterated: Buy | $63 → $67 | $47.04 | n/a | 11 | May 16, 2025 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $55 → $60 | $62.14 | n/a | 18 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €197.00 | €148.75 | n/a | 13 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $29.39 | n/a | 1 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €77.50 | €55.58 | n/a | 1 | Sep 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.33 | n/a | 2 | Sep 15, 2016 |
Roche Holding AG
Nov 4, 2026
Reiterated: Hold
Price Target: CHF 350.00
Current: CHF 390.30
Upside: -10.33%
Sanofi
Nov 4, 2026
Reiterated: Buy
Price Target: €105.00
Current: €83.74
Upside: +25.39%
AstraZeneca PLC
Oct 16, 2026
Reiterated: Buy
Price Target: 15,000p
Current: 13,930p
Upside: +7.68%
AbbVie
Sep 10, 2026
Reiterated: Buy
Price Target: $275
Current: $291.31
Upside: -5.60%
Merck & Co.
Aug 5, 2026
Reiterated: Hold
Price Target: $125 → $127
Current: $146.73
Upside: -13.45%
Novartis AG
Mar 6, 2026
Rated: Hold
Price Target: CHF 92.00 → CHF 110.00
Current: CHF 133.08
Upside: -17.34%
Barratt Redrow plc
Feb 11, 2026
Reiterated: Hold
Price Target: 414p
Current: 333p
Upside: +24.44%
GSK plc
Jan 6, 2026
Reiterated: Hold
Price Target: 1,660p
Current: 1,890p
Upside: -12.17%
Sanofi
May 16, 2025
Reiterated: Buy
Price Target: $63 → $67
Current: $47.04
Upside: n/a
Bristol-Myers Squibb Company
Dec 10, 2024
Reiterated: Hold
Price Target: $55 → $60
Current: $62.14
Upside: n/a
Feb 10, 2022
Reiterated: Hold
Price Target: €197.00
Current: €148.75
Upside: n/a
Jun 14, 2021
Reiterated: Hold
Price Target: $43
Current: $29.39
Upside: n/a
Sep 11, 2018
Reiterated: Hold
Price Target: €77.50
Current: €55.58
Upside: n/a
Sep 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $15.33
Upside: n/a